Predictive models of hepatotoxicity using gene expression data from primary rat hepatocytes

With the aim of evaluating the usefulness of an in vitro system for assessing the potential hepatotoxicity of compounds, the paper describes several methods of obtaining mathematical models for the prediction of compound-induced toxicity in vivo. These models are based on data derived from treating rat primary hepatocytes with various compounds, and thereafter using microarrays to obtain gene expression ‘profiles’ for each compound. Predictive models were constructed so as to reduce the number of ‘probesets’ (genes) required, and subjected to rigorous cross-validation. Since there are a number of possible approaches to derive predictive models, several distinct modelling strategies were applied to the same data set, and the outcomes were compared and contrasted. While all the strategies tested showed significant predictive capability, it was interesting to note that the different approaches generated models based on widely disparate probesets. This implies that while these models may be useful in ascribing relative potential toxicity to compounds, they are unlikely to provide significant information on underlying toxicity mechanisms. Improved predictivity will be obtained through the generation of more comprehensive gene expression databases, covering more ‘toxicity space’, and by the development of models that maximize the observation, and combination, of individual differences between compounds.

[1]  T. Weiser,et al.  Assessment of hepatotoxic liabilities by transcript profiling. , 2005, Toxicology and applied pharmacology.

[2]  D Haussler,et al.  Knowledge-based analysis of microarray gene expression data by using support vector machines. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Tenenhaus,et al.  Prediction of clinical outcome with microarray data: a partial least squares discriminant analysis (PLS-DA) approach , 2003, Human Genetics.

[4]  A. Salter,et al.  Large-scale databases in toxicogenomics. , 2005, Pharmacogenomics.

[5]  S. Ahmed,et al.  A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. , 1994, Journal of immunological methods.

[6]  Robert P Tonge,et al.  Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  K. Morgan Gene expression analysis reveals chemical-specific profiles. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  R G Ulrich,et al.  Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. , 2001, Toxicology and applied pharmacology.

[9]  Vladimir Vapnik,et al.  Statistical learning theory , 1998 .

[10]  Sayan Mukherjee,et al.  Classifying Microarray Data Using Support Vector Machines , 2003 .

[11]  Peter J Park,et al.  Improving identification of differentially expressed genes in microarray studies using information from public databases , 2004, Genome Biology.

[12]  R G Ulrich,et al.  Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. , 2001, Toxicology letters.

[13]  W. Cleveland Robust Locally Weighted Regression and Smoothing Scatterplots , 1979 .

[14]  Yumiko Sakai,et al.  Applications of microarrays with toxicologically relevant genes (tox genes) for the evaluation of chemical toxicants in Sprague Dawley rats in vivo and human hepatocytes in vitro. , 2004, Mutation research.

[15]  Donna L Mendrick,et al.  Toxicogenomics: a new revolution in drug safety. , 2002, Drug discovery today.

[16]  Russell Huby,et al.  Gene expression profiling for pharmaceutical safety assessment , 2005, Expert opinion on drug metabolism & toxicology.